Revestive
Revestive 5 mg powder and solvent for solution for injection is indicated for the treatment of patients aged 1 year and above with Short Bowel Syndrome. Patients should be stable …
See results only from revestive.comHome
Of the 37 Revestive subjects in STEPS, 30 completed 24 months of further …
Short Bowel Syndrome Overv…
Short Bowel Syndrome with intestinal failure is a chronic, highly debilitating and …
Mode of Action
Revestive increased intestinal villus height and crypt depth vs. baseline 3 *In a 21 …
Efficacy
GAVE COMPLETE FREEDOM FROM PN/IV 6. As early as Week 24, 3/26 …
Safety
No new safety signals seen in long-term pooled paediatric data^ of 89 patients …
Managing the Revestive Jour…
A post-hoc analysis* of patients receiving Revestive (n=43) in the STEPS trial, a …
Pediatric Patients
It may be possible with Revestive 8 Revestive is the first and only long-term …
Dosing and Administration
Revestive is given by subcutaneous injection once daily. The recommended …
Revestive 5 mg powder and solvent for solution for injection
Revestive 5 mg powder and solvent for solution for injection - Summary of Product Characteristics (SmPC) - (emc) Active Ingredient: teduglutide. Company: Takeda UK Ltd See contact details. …
Dosing and Administration - Revestive
Revestive is given by subcutaneous injection once daily. The recommended dose is 0.05 mg/kg. Two vial sizes are available: 5.0 mg per vial. 1.25 mg per vial (an option for children who …
Revestive Advanced Patient Information - Drugs.com
- Teduglutide injection is used to treat short bowel syndrome (SBS) in patients who are receiving parenteral nutrition. SBS is a condition that prevents the intestine (bowel) or gut from absorbing food properly. This medicine is available only with your doctor's prescription.
- 9.8/10(4)
- Estimated Reading Time: 8 mins
Teduglutide (subcutaneous route) - Mayo Clinic
Feb 1, 2024 · Description. Teduglutide injection is used to treat short bowel syndrome (SBS) in patients who are receiving parenteral nutrition. SBS is a condition that prevents the intestine …
Revestive - European Medicines Agency (EMA)
Revestive is a medicine for treating short bowel syndrome (or short gut) in adults and children aged 4 months and above. Short bowel syndrome is a condition in which nutrients and fluids …
- People also ask
Revestive is used to treat adults, children and adolescents (aged 4 months and above) with Short Bowel Syndrome. Short Bowel Syndrome is a disorder arising from an inability to absorb food …
REVESTIVE is used to treat adults and pediatric patients 1 year of age and above with Short Bowel Syndrome. Short Bowel Syndrome is a disorder arising from an inability to absorb food …
REVESTIVE® (teduglutide for injection) is indicated for the treatment of adults and pediatric patients 1 year of age and above with Short Bowel Syndrome (SBS) who are dependent on …
Revestive is indicated for the treatment of patients 4 months corrected gestational age and above with Short Bowel Syndrome (SBS). Patients should be stable following a period of intestinal …
Related searches for revestive 5 mg